Basic Information
Basic information for AC002451.1-216-33aa
Peptide Name AC002451.1-216-33aa
Genome Position chr7:95613567-95613665[+]
Species Human
Peptide Sequence MRKSQHRKTENSKNQSALFPTNSHITSPAKVLN
Peptide Length 33
Unique No (AC002451.1-203-33aa,AC002451.1-212-33aa)
Grand Average of Hydropathicity -1.2182
Relative Molecular Mass 4327.82
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000231170;AC002451.1
Transcript ID/Name ENST00000665332;AC002451.1-216
Transcript Length 2118
Coding Ability 0.4736
DNA Sequence Corresponding to Peptide ATGAGAAAGAGTCAGCACAGGAAAACTGAAAACTCGAAAAACCAGAGTGCCCTCTTTCCTACGAACAGCCACATCACCTCTCCAGCAAAGGTTCTGAAC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :